Who
Keithly Garnett
CFO
Company insider
Files Form 4 as: CFO, NeOnc Technologies Holdings.
In numbers
- Trades disclosed
- 21
- Buys
- 6
- Sells
- 3
- Bought
- $12K
- Sold
- $362K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 26 Mar 2025
- Last trade
- 15 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 18 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Sold | $17K5,000 at $3.36 | filing |
| 15 Sep 2026filed 18 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Sold | $17K5,000 at $3.36 | filing |
| 14 Sep 2026filed 15 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $1,001257 at $3.89 | filing |
| 14 Sep 2026filed 15 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $1,000257 at $3.89 | filing |
| 22 May 2025filed 23 May 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $4,921675 at $7.29 | filing |
| 19 May 2025filed 22 May 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $976135 at $7.23 | filing |
| 13 May 2025filed 22 May 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $63190 at $7.01 | filing |
| 13 May 2025filed 19 May 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $63190 at $7.01 | filing |
| 15 Apr 2025filed 24 Apr 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $1,614300 at $5.38 | filing |
| 15 Apr 2025filed 24 Apr 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $1,614300 at $5.38 | filing |
| 26 Mar 2025filed 5 Jun 2025 | NTHI NeOnc Technologies Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code X | —13,438 at $0.00 | filing |
| 26 Mar 2025filed 5 Jun 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Code J | —687 | filing |
| 26 Mar 2025filed 5 Jun 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Code X | $161K13,438 at $12.00 | filing |
| 26 Mar 2025filed 5 Jun 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Sold | $161K6,450 at $25.00 | filing |
| 26 Mar 2025filed 5 Jun 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Sold | $3,176166 at $19.13 | filing |
| 26 Mar 2025filed 8 Apr 2025 | NTHI NeOnc Technologies Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code X | —13,438 at $0.00 | filing |
| 26 Mar 2025filed 8 Apr 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Code J | —687 | filing |
| 26 Mar 2025filed 8 Apr 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Code X | $161K13,438 at $12.00 | filing |
| 26 Mar 2025filed 8 Apr 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Sold | $161K6,450 at $25.00 | filing |
| 26 Mar 2025filed 8 Apr 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Sold | $3,176166 at $19.13 | filing |
News
No headline names them, or the companies they trade most, lately.